【结 构 式】 |
【分子编号】11660 【品名】2-Nitroacetaldehyde oximesodium salt 【CA登记号】 |
【 分 子 式 】C2H3N2NaO3 【 分 子 量 】126.047268 【元素组成】C 19.06% H 2.4% N 22.22% Na 18.24% O 38.08% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(I)Nitroacetaldehyde oxime (I) is formed from nitromethane in the presence of NaOH and is converted in acidic media with 2-aminobenzoic acid (II) to 2-(2-nitroethylideneamino)benzoic acid (III). Cyclization of (III) in acetic anhydride by means of potassium acetate yields 4-hydroxy-3-nitroquinoline (IV), which is converted to 4-chloro-3-nitroquinoline (V) in boiling POCl3. Reaction of (V) with morpholinecarboximidamide (VIII) (formed from morpholine (VI) and S-methylisothiourea hemisulfate (VII) in ethanol) affords troquidazole.
【1】 Berényi, E.; Varga, L.; Pallos, L.; Petöcz, L.; Ladányi, L.; Tömpe, P.; Hartai, E.; Kovács, A. (Egis Pharmaceuticals Ltd.); N-(3-Nitroquinolin-4-yl)guanidine derivatives as radiosensitizers. (EGIS Pharm., Ltd.). BE 0904864; CH 668069; ES 8707231; GB 2176185; JP 1987048668; US 4652562 . |
【2】 Nógrádi, M.; Berényi, E.; Blaskó, G.; Troquidazole. Drugs Fut 1992, 17, 5, 384. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11660 | 2-Nitroacetaldehyde oximesodium salt | C2H3N2NaO3 | 详情 | 详情 | |
(II) | 11661 | 2-Aminobenzoic acid;Anthranilic acid; o-Aminobenzoic acid | 118-92-3 | C7H7NO2 | 详情 | 详情 |
(III) | 11662 | 2-[[(E)-2-Nitroethylidene]amino]benzoic acid | C9H8N2O4 | 详情 | 详情 | |
(IV) | 11663 | 3-Nitro-4-quinolinol; 3-Nitro-quinolin-4-ol | C9H6N2O3 | 详情 | 详情 | |
(V) | 11664 | 4-Chloro-3-nitroquinoline | C9H5ClN2O2 | 详情 | 详情 | |
(VI) | 10388 | Morpholine | 110-91-8 | C4H9NO | 详情 | 详情 |
(VII) | 10272 | [[Amino(imino)methyl]sulfanyl]methane | 2986-19-8 | C2H6N2S | 详情 | 详情 |
(VIII) | 11667 | 4-Morpholinecarboximidamide | C5H11N3O | 详情 | 详情 |
Extended Information